Correction to "Shifting the Antibody-Drug Conjugate Paradigm: A Trastuzumab-Gold-Based Conjugate Demonstrates High Efficacy against Human Epidermal Growth Factor Receptor 2-Positive Breast Cancer Mouse Model". uri icon

Overview

abstract

  • [This corrects the article DOI: 10.1021/acsptsci.3c00270.].

publication date

  • January 3, 2024

Identity

PubMed Central ID

  • PMC10789141

Scopus Document Identifier

  • 85183376860

Digital Object Identifier (DOI)

  • 10.1021/acsptsci.3c00364

PubMed ID

  • 38230288

Additional Document Info

volume

  • 7

issue

  • 1